• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌低 PSA 生化复发患者中,68Ga-前列腺特异性膜抗原探测到的小淋巴结转移,但 18F-氟氯维司 PET/CT 未探测到。

Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer.

机构信息

From the Division of Nuclear Medicine, Department of Radiology, McGill University, Montreal, Quebec, Canada.

出版信息

Clin Nucl Med. 2018 Apr;43(4):250-251. doi: 10.1097/RLU.0000000000002009.

DOI:10.1097/RLU.0000000000002009
PMID:29465489
Abstract

A 58-year-old man with Gleason 4+3 prostate cancer was initially treated by radical prostatectomy followed by salvage radiotherapy to the prostate bed for postoperative biochemical failure. One year later, F-fluorocholine PET/CT detected a pelvic lymph node recurrence, which was treated with radiation therapy and 6 months of androgen deprivation. PSA started to rise again 18 months later, but F-fluciclovine PET/CT failed to demonstrate the site of recurrence at a PSA of 0.63 ng/mL. However, Ga-PSMA PET/CT revealed a single positive 4-mm perirectal lymph node (PSA 0.80 ng/mL at time of scan), in retrospect anatomically apparent but negative on F-fluciclovine PET/CT.

摘要

一位 58 岁的男性,患有 Gleason 4+3 前列腺癌,最初接受了根治性前列腺切除术,随后对前列腺床进行挽救性放疗,以治疗术后生化失败。一年后,F-氟代胆碱 PET/CT 检测到盆腔淋巴结复发,采用放疗和 6 个月的雄激素剥夺治疗。18 个月后 PSA 再次升高,但 F-氟代胆碱 PET/CT 在 PSA 为 0.63ng/ml 时未能显示复发部位。然而,Ga-PSMA PET/CT 显示单个阳性 4mm 直肠旁淋巴结(扫描时 PSA 为 0.80ng/ml),回顾性分析解剖学上可见,但在 F-氟代胆碱 PET/CT 上为阴性。

相似文献

1
Small Lymph Node Metastasis Detected by 68Ga-Prostate-Specific Membrane Antigen But Not 18F-Fluciclovine PET/CT in Low-Prostate-Specific Antigen Biochemical Recurrence of Prostate Cancer.前列腺癌低 PSA 生化复发患者中,68Ga-前列腺特异性膜抗原探测到的小淋巴结转移,但 18F-氟氯维司 PET/CT 未探测到。
Clin Nucl Med. 2018 Apr;43(4):250-251. doi: 10.1097/RLU.0000000000002009.
2
F-fluciclovine PET-CT and Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.氟[¹⁸F]氟代脱氧葡萄糖 PET-CT 和镓[⁶⁸Ga]前列腺特异性膜抗原-11 PET-CT 在前列腺癌根治术后早期生化复发患者中的应用:一项前瞻性、单中心、单臂、对比成像试验。
Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30.
3
Comparison of Ga-PSMA-11 and F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence.10 例前列腺癌复发患者的 Ga-PSMA-11 和 F-Fluciclovine PET/CT 比较病例系列研究
J Nucl Med. 2018 May;59(5):789-794. doi: 10.2967/jnumed.117.203257. Epub 2017 Dec 14.
4
Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.在 PSA 水平低于 1.0ng/ml 的 270 例患者中,Ga-PSMA-11 PET/CT 对前列腺癌根治术后生化复发的定位:对挽救性放疗计划的影响。
J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.
5
A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT.18F-氟戊氨酸与 68Ga-PSMA-11 在前列腺癌 PET/CT 生化复发中的前瞻性头对头比较
Clin Nucl Med. 2019 Oct;44(10):e566-e573. doi: 10.1097/RLU.0000000000002703.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.镓-PSMA-11 PET/CT 在根治性前列腺切除术后生化复发且 PSA<0.5ng/ml 的前列腺癌患者中的应用。疗效及对治疗策略的影响。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):11-19. doi: 10.1007/s00259-018-4066-4. Epub 2018 Jun 15.
8
Clinicopathological predictors of positive Ga-PSMA-11 PET/CT in PSA-only recurrence of localized prostate cancer following definitive therapy.明确治疗后局部前列腺癌 PSA 唯一复发时 Ga-PSMA-11 PET/CT 阳性的临床病理预测因素。
Ann Nucl Med. 2019 May;33(5):326-332. doi: 10.1007/s12149-019-01340-1. Epub 2019 Feb 18.
9
Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.镓-PSMA-11 PET/CT 在复发性前列腺癌中的应用:根治性治疗后 PSA 失败不同临床阶段的疗效。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):31-39. doi: 10.1007/s00259-018-4189-7. Epub 2018 Oct 22.
10
Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?根治性治疗后前列腺癌患者 PSA 检测不到时,18F-氟氯维司 PET/CT 是否有作用?
Clin Nucl Med. 2020 Sep;45(9):672-678. doi: 10.1097/RLU.0000000000003122.

引用本文的文献

1
Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer.氟代脱氧胸苷正电子发射断层扫描在前列腺癌局部治疗后生化复发中的应用
Transl Androl Urol. 2018 Oct;7(5):824-830. doi: 10.21037/tau.2018.07.17.